Moxonidine

CAS 75438-57-2 6 current records 2 historicalSmall Molecule

Who holds supplier records for Moxonidine? 6 organisations hold a current record for Moxonidine: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), Germany (1), Spain (1) and Israel (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Moxonidine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/moxonidine

Reading the evidence

  • 6 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (6)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Moxonidine. Country is the organisation's recorded country, not necessarily the manufacturing site.

India2Germany1Spain1Israel1Country not recorded for 1
Need Moxonidine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Moxonidine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 9 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
MICRO LABS LIMITED BengaluruIN
CEP 2025-322 - Rev 01
Moxonidine
Sept 2026—
CZECH-GEN A.S. OlomoucCZ
CEP 2008-266 - Rev 04
Moxonidine
Jul 2026Inspected Sept 2024
Czechia
NEULAND LABORATORIES LIMITED HyderabadIN
CEP 2013-175 - Rev 04
Moxonidine
Jun 2026—
WAVELENGTH ENTERPRISES LTD. Petah TikvaIL
CEP 2005-009 - Rev 11
Moxonidine
Oct 2024—
KINSY, S.L. MurciaES
R1-CEP 2014-357 - Rev 00
Moxonidine
Jun 2021—
AREVIPHARMA GMBH RadebeulDE
R1-CEP 2013-122 - Rev 00
Moxonidine
Jan 2020—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Moxonidine are no longer active. These show a past filing, not current supply.

Show all 2 historical records

Overview

Moxonidine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL19236).

Chemical identity

IUPAC name
4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methylpyrimidin-5-amine
Canonical SMILES
CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC
InChIKey
WPNJAUFVNXKLIM-UHFFFAOYSA-N
Synonyms
BDF-5896, BDF5896, BE-5895, BE5895, Cynt, Fisiotens, LY-326869, LY326869, Moxonidina, Moxonidine, Normatens, Physiotens

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Moxonidine?

6 organisations hold an active US FDA Type II Drug Master File or a CEP for Moxonidine: Arevipharma GmbH (Germany), CZECH-GEN AS, KINSY, S.L. (Spain), MICRO LABS LTD (India), Neuland Laboratories Limited (India) and WAVELENGTH ENTERPRISES LTD (Israel). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

What do the historical Moxonidine records mean?

2 organisations have only inactive Type II DMFs for Moxonidine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Moxonidine have a European Certificate of Suitability?

Yes. 6 organisations hold a valid CEP for Moxonidine on the EDQM register, including MICRO LABS LIMITED Bengaluru (IN), CZECH-GEN A.S. Olomouc (CZ), NEULAND LABORATORIES LIMITED Hyderabad (IN), WAVELENGTH ENTERPRISES LTD. Petah Tikva (IL), KINSY, S.L. Murcia (ES) and AREVIPHARMA GMBH Radebeul (DE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Moxonidine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Moxonidine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.